BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
370 results:

  • 1. A practical nomogram for predicting early death in elderly small cell lung cancer patients: A SEER-based study.
    Chen R; Liu Y; Tou F; Xie J
    Medicine (Baltimore); 2024 Apr; 103(17):e37759. PubMed ID: 38669410
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced cancer Enrolled in Randomized Trials.
    Lund JL; Cacciatore J; Tylock R; Su IH; Sharma S; Hinton SP; Smith S; Nowels MA; Chen X; Duberstein PR; Hanson LC; Mohile SG
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300183. PubMed ID: 38564692
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Noscapine and Apoptosis in Breast and Other cancers.
    Calaf GM; Crispin LA; Quisbert-Valenzuela EO
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Non-tumor-related prognostic factors for immunotherapy-chemotherapy or immunotherapy alone as first-line in advanced non-small cell lung cancer (NSCLC).
    Guo Z; Wei X; Tang C; Liang J
    Clin Exp Med; 2024 Mar; 24(1):52. PubMed ID: 38489142
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of smoking cessation duration on lung cancer mortality: A systematic review and meta-analysis.
    Lai H; Liu Q; Ye Q; Liang Z; Long Z; Hu Y; Wu Q; Jiang M
    Crit Rev Oncol Hematol; 2024 Apr; 196():104323. PubMed ID: 38462148
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.
    Zupanc C; Franko A; Štrbac D; Kovač V; Dolžan V; Goričar K
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203360
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.
    Kang DW; Park SK; Yu YL; Lee Y; Lee DH; Kang S
    ESMO Open; 2024 Jan; 9(1):102200. PubMed ID: 38194884
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A diagnostic model based on
    Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X
    BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PM
    Bryan L; Landrigan P
    Front Public Health; 2023; 11():1286755. PubMed ID: 38106908
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
    Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
    Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis.
    Manetsch P; Böhi F; Nowak K; Leslie Pedrioli DM; Hottiger MO
    Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2309047120. PubMed ID: 38011562
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel lupene derivative from Thymus capitatus possesses an apoptosis-inducing effect via Let-7 miRNA/Cyclin D1/VEGF cascade in the A549 cell line.
    Aborehab NM; Salama MM; Ezzat SM
    BMC Complement Med Ther; 2023 Oct; 23(1):365. PubMed ID: 37845669
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
    Adamo A; Frusteri C; Pilotto S; Caligola S; Belluomini L; Poffe O; Giacobazzi L; Dusi S; Musiu C; Hu Y; Wang T; Rizzini D; Vella A; Canè S; Sartori G; Insolda J; Sposito M; Incani UC; Carbone C; Piro G; Pettinella F; Qi F; Wang D; Sartoris S; De Sanctis F; Scapini P; Dusi S; Cassatella MA; Bria E; Milella M; Bronte V; Ugel S
    Oncoimmunology; 2023; 12(1):2253644. PubMed ID: 37720688
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma.
    Li X; Chen J; Zhang C; Han Z; Zheng X; Cao D
    BMC Pulm Med; 2023 Sep; 23(1):339. PubMed ID: 37697337
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women.
    Tschiderer L; Peters SAE; van der Schouw YT; van Westing AC; Tong TYN; Willeit P; Seekircher L; Moreno-Iribas C; Huerta JM; Crous-Bou M; Söderholm M; Schulze MB; Johansson C; Själander S; Heath AK; Macciotta A; Dahm CC; Ibsen DB; Pala V; Mellemkjær L; Burgess S; Wood A; Kaaks R; Katzke V; Amiano P; Rodriguez-Barranco M; Engström G; Weiderpass E; Tjønneland A; Halkjær J; Panico S; Danesh J; Butterworth A; Onland-Moret NC
    J Am Heart Assoc; 2023 Sep; 12(18):e030280. PubMed ID: 37681566
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas.
    Lim WH; Lee KH; Lee JH; Park H; Nam JG; Hwang EJ; Chung JH; Goo JM; Park S; Kim YT; Kim H
    Eur Radiol; 2024 Mar; 34(3):1934-1945. PubMed ID: 37658899
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell lung cancer.
    Ye Y; Yang Y; Yan L; Zhou L; Yu S; Du Q; Dong X; Yuan Q; Shan L; Guo L
    Drug Des Devel Ther; 2023; 17():2461-2479. PubMed ID: 37637262
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
    Fares AF; Li Y; Jiang M; Brown MC; Lam ACL; Aggarwal R; Schmid S; Leighl NB; Shepherd FA; Wang Z; Diao N; Wenzlaff AS; Xie J; Kohno T; Caporaso NE; Harris C; Ma H; Barnett MJ; Leal LF; Fernandez-Tardon G; Pérez-Ríos M; Davies MPA; Taylor F; Schöttker B; Brennan P; Zaridze D; Holcatova I; Lissowska J; Świątkowska B; Mates D; Savic M; Brenner H; Andrew A; Cox A; Field JK; Ruano-Ravina A; Shete SS; Tardon A; Wang Y; Le Marchand L; Reis RM; Schabath MB; Chen C; Shen H; Ryan BM; Landi MT; Shiraishi K; Zhang J; Schwartz AG; Tsao MS; Christiani DC; Yang P; Hung RJ; Xu W; Liu G
    Lancet Public Health; 2023 Sep; 8(9):e691-e700. PubMed ID: 37633678
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetically predicted childhood body mass index and lung cancer susceptibility: A two-sample Mendelian randomization study.
    Wu D; Zhou J; Huang Y; Zheng Q; Wang T; Liu L
    Cancer Med; 2023 Sep; 12(17):18418-18424. PubMed ID: 37548289
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study.
    Ma Y; Chen Q; Zhang Y; Xue J; Liu Q; Zhao Y; Yang Y; Huang Y; Fang W; Hou Z; Li S; Wang J; Zhang L; Zhao H
    Cancer Chemother Pharmacol; 2023 Nov; 92(5):411-418. PubMed ID: 37518060
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.